As PPARγ is able to suppress GcG expression in mice, we suggest that the increased activation of PPARγ gene expression observed in the current study (Figure 2A) possibly leads to dysregulated GLP-1 secretion and, further, exacerbates hyperglycemia. Here, PPARG is linked to Hyperglycemia.